FA
IPXL

FDx Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

FDx Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,100
Closed -$942K – 1054
2015
Q1 		$942K Sell
20,100
-3,659
-15% -$146K 0.02% 625
2014
Q4 		$753K Buy
23,759
+938
+4% +$27.5K 0.05% 403
2014
Q3 		$541K Sell
22,821
-2,244
-9% -$57.5K 0.04% 550
2014
Q2 		$752K Buy
+25,065
New +$676K 0.05% 428

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

FDx Advisors's IPXL Position: Q2 2015 in Review

FDx Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2015, closing a stake of 20,100 shares — an estimated $942K sold.

FDx Advisors first reported a position in IPXL in Q2 2014 and held it in 4 quarters. The position peaked at $942K in Q1 2015. 197 funds tracked by Wall St. Rank hold IPXL as of Q2 2015.

  • FDx Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2015 after selling out during the quarter.
  • FDx Advisors sold 20,100 Impax Laboratories, Inc. shares in Q2 2015, an estimated $942K.
  • FDx Advisors first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 4 quarters.
  • FDx Advisors's Impax Laboratories, Inc. position peaked at $942K in Q1 2015.
  • 197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2015.

Based on FDx Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.